FDA Drug Application (022110) for VIBATIV by THERAVANCE BIOPHARMA

Back to FDA Applications sponsored by THERAVANCE BIOPHARMA

Application Number022110
Product Number001
FormPOWDER;IV (INFUSION)
DosageEQ 250MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameVIBATIV
Active IngredientTELAVANCIN HYDROCHLORIDE



Back to FDA Applications sponsored by THERAVANCE BIOPHARMA